Regulator or regulatory shield? The case for reforming Canada’s Patented Medicine Prices Review Board

Prescription drug prices in Canada are regulated by a federal agency. In 1987, the Patent Act introduced a major overhaul that strengthened patent protection for drugs to encourage more pharmaceutical research and development in Canada.[1][1] The act also created the Patented Medicine Prices Review